US$ 20.01
retatrutide phase 2 trial type 2 diabetes Advancements in Clinical Research and Development of Obesity Treatment Medications Retatrutide as a Novel Treatment
Description
Front Pharmacol 2024

What you need before starting Gather everything first
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)
These drugs act on brain pathways involved in appetite regulation and reward

It would also be useful to know whether there is a role of GLP-1 analogs in treating IBD, including ulcerative colitis, in patients without type 2 diabetes or obesity and the safety of doing so

The safety profile supported progression to Phase 2 trials
